RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Hiroshi Matsui to Immunophenotyping

Back to Details
This is a "connection" page, showing publications Hiroshi Matsui has written about Immunophenotyping.
Hiroshi Matsui
Connection Strength
0.042
Immunophenotyping
  1. Taniguchi Y, Ishida M, Saito T, Ryota H, Utsumi T, Maru N, Matsui H, Hino H, Tsuta K, Murakawa T. Preferentially expressed antigen in melanoma as a novel diagnostic marker differentiating thymic squamous cell carcinoma from thymoma. Sci Rep. 2020 07 23; 10(1):12286.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support